Request More Information:
Recent News
- Jun 14, 2011
Phase 2 Study of Two Potential CF Therapies — VX-770 and VX-809 — Shows Promising Results in Patients with Most Common Mutation
- Feb 23, 2011
TRIAL SHOWS CYSTIC FIBROSIS DRUG HELPED EASE BREATHING
- Nov 10, 2010
Vertex Pharmaceuticals Initiates Clinical Trial to Evaluate Combination Regimens of VX-770 and VX-809 Targeting the Defective Protein Responsible for Cystic Fibrosis
